Rodés J - Search Results

1

Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.

Ruiz del Arbol L, García-Pagán JC, Feu F, Pizcueta MP, Bosch J, Rodés J. Ruiz del Arbol L, et al. Among authors: rodes j. J Hepatol. 1991 Sep;13(2):179-86. doi: 10.1016/0168-8278(91)90812-p. J Hepatol. 1991. PMID: 1744422 Clinical Trial.

2

Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis.

García-Pagán JC, Navasa M, Rivera F, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: rodes j. Gastroenterology. 1992 Jun;102(6):2015-23. doi: 10.1016/0016-5085(92)90327-u. Gastroenterology. 1992. PMID: 1316859

3

Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy.

Panés J, Bordas JM, Piqué JM, Bosch J, García-Pagán JC, Feu F, Casadevall M, Terés J, Rodés J. Panés J, et al. Among authors: rodes j. Gastroenterology. 1992 Dec;103(6):1875-82. doi: 10.1016/0016-5085(92)91447-c. Gastroenterology. 1992. PMID: 1451980

4

Portal hypertension in acute liver failure.

Navasa M, Garcia-Pagán JC, Bosch J, Riera JR, Bañares R, Mas A, Bruguera M, Rodés J. Navasa M, et al. Among authors: rodes j. Gut. 1992 Jul;33(7):965-8. doi: 10.1136/gut.33.7.965. Gut. 1992. PMID: 1644339 Free PMC article.

5

Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.

Pizcueta MP, García-Pagán JC, Fernández M, Casamitjana R, Bosch J, Rodés J. Pizcueta MP, et al. Among authors: rodes j. Gastroenterology. 1991 Dec;101(6):1710-5. doi: 10.1016/0016-5085(91)90411-d. Gastroenterology. 1991. PMID: 1683327

6

Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.

Nevens F, Pizcueta MP, Fernández M, Bosch J, Rodés J. Nevens F, et al. Among authors: rodes j. Hepatology. 1991 Dec;14(6):1174-8. Hepatology. 1991. PMID: 1959867

7

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.

García-Pagán JC, Feu F, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: rodes j. Ann Intern Med. 1991 May 15;114(10):869-73. doi: 10.7326/0003-4819-114-10-869. Ann Intern Med. 1991. PMID: 2014947 Clinical Trial.

8

Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension.

Feu F, Bordas JM, Garcia-Pagán JC, Bosch J, Rodés J. Feu F, et al. Among authors: rodes j. Hepatology. 1991 May;13(5):917-22. Hepatology. 1991. PMID: 2029996 Clinical Trial.

9

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.

García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: rodes j. J Hepatol. 1990 Sep;11(2):189-95. doi: 10.1016/0168-8278(90)90112-5. J Hepatol. 1990. PMID: 2123914 Clinical Trial.

10

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J. Garcia-Pagán JC, et al. Among authors: rodes j. Hepatology. 1990 Feb;11(2):230-8. doi: 10.1002/hep.1840110212. Hepatology. 1990. PMID: 2307401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

730 results

Search Page

Filters